Karolinska Institutet (KI) and the Mayo Clinic are strengthening their long-standing partnership, with a recent visit to Mayo Clinic's Florida campus highlighting new opportunities for joint research and infrastructure development.
According to KI, the collaboration, which spans more than three decades, is strategically important for both institutions. Martin Bergö, Vice President of Karolinska Institutet, said in a statement that international partnerships with leading research environments like Mayo Clinic are vital for strengthening KI's research and creating new opportunities for its researchers. "By combining our expertise and resources, we can advance research and contribute to better health," Bergö said.
During a visit on 19 October, Sophie Erhardt, Professor of Experimental Psychiatry and Academic Coordinator for the KI-Mayo Clinic collaboration, and Elham Rostami, Associate Professor of Neurosurgery and Director of KI HumanLab, presented KI's research platforms to Mayo Clinic researchers. KI HumanLab, based at Bioclinicum in Solna near Karolinska University Hospital, allows researchers and clinicians from different fields to study the same participant in multiple ways during a single visit. ExtremeLab, a complementary initiative, provides equipment to study human performance and the ability to withstand extreme environments.
Mayo Clinic Florida is currently developing its "Lab of the Future," scheduled to open in 2029. KI reported that Mayo Clinic showed strong interest in how KI HumanLab was organised and built up. Following the presentation, Mayo Clinic's consortium for research in emergency and intensive care initiated discussions about collaborating with the platform. Erhardt noted that developing research infrastructure in parallel creates opportunities to facilitate joint research from the outset. "Mayo Clinic has a clear research strategy, and KI has prioritised areas such as precision medicine and prevention. When we develop the infrastructure in parallel, we can find ways to make the systems work together," she said.
Erhardt, who has coordinated the collaboration since 2019, emphasised that shared values and personal relationships are key to the partnership's longevity. She described a concept called "friendlation"—a blend of friendship and collaboration. "We know and trust each other and stay in touch even when there is no finished project. This allows new ideas to emerge and continue even when people move on," Erhardt said.
The institutions complement each other, according to KI. Mayo Clinic has strong platforms for automation and data management, while KI and Karolinska University Hospital have strengths in registers, cohorts, and clinical research. Mayo Clinic's biobank contains 6.1 million samples that researchers can search, and its research administration uses more than 60 AI tools.
Going forward, KI and Mayo Clinic will announce seed grants and travel grants to support joint research projects. Researcher exchanges are also a key component. One example is doctoral student Patrik Fridh, who is spending several weeks at Mayo Clinic in Rochester working with Professor Doo-Sup Choi on how cellular processes and interactions between brain cells affect brain function and contribute to neurological and psychiatric diseases.
There is also an established collaboration in cancer research. Elias Arnér, Chair of Cancer Research KI (CRKI), described the partnership as highly rewarding. CRKI and Mayo Clinic launched a joint research programme in 2019 focusing on breast cancer, which was expanded in 2022 to include all forms of cancer. Between 2020 and 2025, the programme funded 16 two-year projects with a total of SEK 18.75 million. Since 2021, the parties have also organised joint symposia. The success has led to a call for applications for the CRKI–Mayo CCC Synergy Grant, a four-year research grant of SEK 2.5 million per year at KI, with matching funding at Mayo Clinic. "It will be exciting to see which applications are submitted and what our continued collaboration may lead to," Arnér said.
Next steps include an initial meeting on KI HumanLab planned for December, with Mayo Clinic's Sebastian Fernandez-Bussy and Brian Hultgren visiting KI. Discussions on joint research areas, infrastructure, and new collaborations will continue at the annual joint conference in Jacksonville on 15–16 March 2027.
The broader partnership between KI and Mayo Clinic covers research, education, innovation, and administration. More than 3,000 students, researchers, and staff have participated in activities at the two institutions. The five joint research themes are RNA-based therapies, transplantation and regenerative medicine, cancer, biobanks and precision medicine, and brain, cardiometabolic health and immunity.
For students and researchers at KI, this expansion means more opportunities for international research experience, access to Mayo Clinic's advanced infrastructure and biobank, and potential funding for collaborative projects. The partnership also offers a model for how academic medical centres can work together across continents to accelerate the translation of research into clinical practice.